Phase I Trial of Concomitant Hyperfractionated Radiotherapy With Docetaxel and Cisplatin for Locally Advanced Head and Neck Cancer

Cancer Journal - United States
doi 10.1097/00130404-200601000-00011
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)